Update of the stroke therapy academic industry roundtable preclinical recommendations - Wikidata - wikimedia - TriplyDB

Update of the stroke therapy academic industry roundtable preclinical recommendations

Update of the stroke therapy academic industry roundtable preclinical recommendations

http://www.wikidata.org/entity/Q29615508

about

Identification of new epilepsy treatments: issues in preclinical methodology A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation A call for transparent reporting to optimize the predictive value of preclinical research Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism Selective ROCK2 inhibition in focal cerebral ischemia Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window Big data from small data: data-sharing in the 'long tail' of neuroscience Molecular pathophysiology of cerebral edema The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke Complement in the Homeostatic and Ischemic Brain Neuroprotection for traumatic brain injury Oxidative Stress and the Use of Antioxidants in Stroke Neuroprotection for stroke: current status and future perspectives Current understanding of TRPM7 pharmacology and drug development for stroke Stress as necessary component of realistic recovery in animal models of experimental stroke Nonhuman primate models of stroke for translational neuroprotection research.Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress Cerebral ischemic stroke: is gender important?Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.Stem cell therapy for neonatal hypoxic-ischemic encephalopathy Biomarkers for ischemic preconditioning: finding the responders The transcriptome of cerebral ischemia Issues related to development of antiepileptogenic therapies.Cell based therapies for ischemic stroke: from basic science to bedside Anti-epileptogenic clinical trial designs in epilepsy: issues and options Effect of cardiac arrest on cognitive impairment and hippocampal plasticity in middle-aged rats.Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke.Human Motor Cortex Functional Changes in Acute Stroke: Gender Effects Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice.Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration A surgical model of permanent and transient middle cerebral artery stroke in the sheep Emergent properties of neural repair: elemental biology to therapeutic concepts Biomechanical Characteristics of Osteoporotic Fracture Healing in Ovariectomized Rats: A Systematic Review.Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke Escaping the Adverse Impacts of NSAIDs on Tooth Movement During Orthodontics: Current Evidence Based on a Meta-Analysis Nonsurgical therapy for hydrocephalus: a comprehensive and critical review Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury Developing Cellular Therapies for Stroke

P2860

Q24289140-2EFFE765-1D01-45FC-BFDC-B54AD7B667BC Q24289291-36938BB7-7D02-4E4D-B780-90FC92C0B324 Q24289327-E3AA81E1-30C6-4998-848A-5CA1F4B7138C Q24289348-7F2F9058-861F-4C4D-9CE7-480A978C63B3 Q24614558-5C7C0736-D359-4A33-8E72-4B09005B0597 Q24615554-1AF2E371-99F0-4A4D-8467-B0088C4D649A Q24790499-A35D7C06-9B92-4401-93DB-53E7876BCBC0 Q26776371-DD7CC175-464C-4144-A5F0-65CC403BDCE8 Q26776379-4CE75A85-2960-4FF0-AC17-91DC957343DA Q26796057-BB35114E-F911-468C-B025-3562035E8371 Q26824808-4238DC80-6BFF-45C9-AD87-FC9D43F43EB6 Q26852796-230197AA-03C2-442B-8410-D7BEFAF0A634 Q26853031-939599B5-8D7E-4358-8DFD-F1DEDD2D87A9 Q26853706-1C68C10D-0120-4471-9C53-88FE7629C277 Q26858828-922C52EA-491A-47ED-9992-0DAEF69C41D8 Q26859430-754ED59F-1AA9-4CDC-9E6F-1E0F2F558F78 Q26862779-B89027D0-2D0E-487A-8DEF-F3920B3C8771 Q26863282-942C4B78-74C8-4C90-ACD4-73E7FD817D49 Q26865843-407AC3ED-FFD5-4419-A017-92A43F90830C Q26866231-3F306B67-B9ED-4671-AFF4-DACC5DA4E34C Q27003906-8AA90202-84E1-4F0C-A75F-9F409B5E655A Q27015878-E3C10BCA-8D1C-42DF-A45A-C97871E93B2F Q27015999-01DDE224-5261-44F4-92D5-D714DC856E2A Q27016115-1A8A2D72-C312-4E44-8ABA-125C0265A837 Q27025754-37914A5B-9F8F-4753-A077-ECBE7AB29B01 Q27027689-4BB4842C-1C21-43F3-87AE-D4710416A4F8 Q27308866-4D2AC222-CFE9-4CFB-A71C-87D1BF7F5AAE Q27311387-AE98374A-9081-41BD-85A9-BDD8B93F3B5B Q27313569-84AC4A16-6CE1-431F-AF8F-9F128729E24B Q27321286-6EB3371B-7CD8-40BC-BEBC-55ED83D8F9D6 Q27323209-B0565698-4302-47FF-AE5D-C55C710DAF09 Q27329027-47ACF75A-CA75-47B2-8966-75D121683B4B Q28067303-500ACBAA-D4CB-4F9B-957E-30DC04AB0672 Q28069977-2A6D01AA-A7B7-4E04-AB5A-D4591CFA57D0 Q28073784-D361BC76-0720-44F7-8AF6-58D54E32F5E5 Q28079034-18A4C0E3-862A-4514-B7DD-5FDFC0E5C5B1 Q28079392-8C6B9B4E-F55C-401C-967D-5886FCE35382 Q28082979-7F125EAE-EBE3-4633-B0A9-1431181E6EB1 Q28085174-492E69C1-39AF-4293-9333-2100489FAE38 Q28087451-1FB8BE7C-D4E8-4CF0-B09D-61A24C702D81

P2860

Update of the stroke therapy academic industry roundtable preclinical recommendations

http://www.wikidata.org/entity/Q29615508

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Update of the stroke therapy academic industry roundtable preclinical recommendations

@ast

Update of the stroke therapy academic industry roundtable preclinical recommendations

@en

type

label

Update of the stroke therapy academic industry roundtable preclinical recommendations

@ast

Update of the stroke therapy academic industry roundtable preclinical recommendations

@en

prefLabel

Update of the stroke therapy academic industry roundtable preclinical recommendations

@ast

Update of the stroke therapy academic industry roundtable preclinical recommendations

@en

P1433

Q29615508-116933CC-32E5-4811-9DD2-CAB1E6003149

P1476

Q29615508-B2F911E5-5753-4283-920B-6AD66002BD8D

P2093

Q29615508-25DBB273-E5CB-4BC6-9108-7384EDB24823

Q29615508-350F3E0F-4D71-4C83-A79D-151BCE4490BA

Q29615508-47C25030-B07C-4F88-B542-F30703D57048

Q29615508-6AE04CB3-0CFB-4BCA-AA5A-137F198872EF

Q29615508-C80588B4-55EB-48A4-93B0-F3744306D484

Q29615508-EA17C159-2143-4482-8B7E-69E84DAA9372

Q29615508-F6226ADF-DD21-4009-8286-9F71817B3FF1

P2860

Q29615508-01FB21BF-AEE4-41D7-B6A4-9FDC6C195669

Q29615508-054CAE9F-AA30-49A3-B379-14BB7621CD31

Q29615508-0C201EB8-BBA4-4786-9EED-03A5392E7CE1

Q29615508-106DB7CB-0375-42D8-86C2-86AF6A8CB505

Q29615508-27287341-9BED-4226-839B-8CFD9377A83E

Q29615508-2AC16C9F-B2E2-4B5C-BFA7-6E664323A7E3

Q29615508-3163E98E-F129-4CC0-A6E0-AB568C9A81E1

Q29615508-36E9C4AF-5D90-4F2F-8CDB-33FF00CDB8A0

Q29615508-4AAC684D-AE86-4695-BE34-79368A144FEB

Q29615508-5C55D911-DFC4-466D-AFCA-980A4E3442BC

P304

Q29615508-EB885286-881D-4390-AD85-4DAC4B4FA71C

P31

Q29615508-B77A93A5-4D52-4DE9-9443-2D000CD5C860

P3181

Q29615508-3216C136-2130-4919-8824-5F38DC4EA6DB

P356

Q29615508-8AEFFC8A-650D-4F1B-86EA-696EB37A55C1

P407

Q29615508-9D206D26-D416-48E5-A60A-CD83957FAA6B

P433

Q29615508-3AC76744-C50D-4F89-A578-1C01C3225305

P478

Q29615508-DEA2C0D2-0EE6-4056-9326-509C68F0A562

P577

Q29615508-66061B2E-BB38-4F65-9DE7-8201AF622DE1

P698

Q29615508-D4E93B8A-1944-48C4-9CE7-371DF009461B

P932

Q29615508-F06A4574-BB62-4A5A-A1E2-75ED4DBB6FEB

P3181

P356

STROKEAHA.108.541128

P1433

P1476

Update of the stroke therapy academic industry roundtable preclinical recommendations

@en

P2093

Feuerstein G

http://www.w3.org/2001/XMLSchema#string

Fisher M

http://www.w3.org/2001/XMLSchema#string

Howells DW

http://www.w3.org/2001/XMLSchema#string

Hurn PD

http://www.w3.org/2001/XMLSchema#string

Kent TA

http://www.w3.org/2001/XMLSchema#string

Lo EH

http://www.w3.org/2001/XMLSchema#string

Savitz SI

http://www.w3.org/2001/XMLSchema#string

P2860

NXY-059 for acute ischemic stroke

1,026 experimental treatments in acute stroke

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Tissue plasminogen activator for acute ischemic stroke

Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats.

A new penumbra: transitioning from injury into repair after stroke.

Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.

Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?

P304

2244-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

818657

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/STROKEAHA.108.541128

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19246690

http://www.w3.org/2001/XMLSchema#string

P932

2888275

http://www.w3.org/2001/XMLSchema#string